Eli Lilly and J&J bounce on new data, as software stocks give up last week's gains

Eli Lilly and J&J bounce on new data, as software stocks give up last week's gains
4 stocks to watch on Monday: LLY, NVO, APO, TTE
4 stocks to watch on Tuesday: JPM, LLY, USB, PANW
4 stocks to watch on Tuesday: META, LLY, BA, TAK
1.12TUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US5324571083
CUSIP
532457108
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
42.20
PEG Ratio
1.58
Book Value
38.00
Dividend Share
6.46
Dividend Yield
0.52%
Earnings Share
29.75
Wall Street Target Price
1,315.04
EPS Estimate Current Year
36.71
EPS Estimate Next Year
47.23
EPS Estimate Current Quarter
6.5845
EPS Estimate Next Quarter
9.4796
Most Recent Quarter
-
Revenue TTM
79,666,003,968
Gross Profit TTM
66,440,998,912
EBITDA
41,706,999,808
Profit Margin
33.53%
Return On Assets TTM
20.36%
Return On Equity TTM
102.29%
Revenue Per Share TTM
89.022
Qtly Revenue Growth YOY
47.70%
Diluted Eps TTM
29.75
Qtly Earnings Growth YOY
26.20%
Trailing PE
42.20
Forward PE
34
Price Sales TTM
14.0523
Price Book MRQ
33.0296
Enterprise Value Revenue
14
Enterprise Value EBITDA
27
467.65
1.99%58.21
1.68%273.45
1.19%444.00
1.07%468.10
0.67%166.71
0.47%157.61
0.00%150.67
-1.25%158.02
-0.56%264.59
-0.12%